Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NPC-06 for Acute Pain in Herpes Zoster
NCT04139330Phase 2Terminated
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Nov 2019
- Primary completion
- Feb 2021
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fosphenytoin in herpes zoster (HZ) (3 arms), sponsored by Nobelpharma Co., Ltd. Primary endpoint: The improvement of NRS (Numeric Rating Scale) score. Started Nov 2019; status: terminated.
02
Drugs
fosphenytoin
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT04139330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04139330.